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ABSTRACT
Introduction: Carbon monoxide (CO) poisoning may cause severe cellular hypoxia.
Materials and methods: A 28-year-old male presented reduced levels of consciousness and dyspnoea after CO exposure. Clinical examination 
revealed tachypnoea, bilateral rales, dilated jugular veins and confusion. Troponin I, lactate and carboxyhaemoglobin levels were increased. 
Thoracic X-ray depicted pulmonary oedema and an echocardiogram, severe heart failure (HF; EF<25%). He was intubated due to clinical 
deterioration.
Results: He remained intubated for 5 days with excellent improvement of left ventricular function (EF>55%). He was discharged 1 week later 
with full recovery. 
Discussion: Acute HF is a rare serious complication of CO poisoning, even in healthy young individuals.
LEARNING POINTS
• Acute CO poisoning is an emergent condition necessitating prompt diagnosis and treatment.
• Neurologic and cardiovascular manifestations are the most worrying complications, which may leave permanent sequelae. 
• Acute heart failure is a rare complication of CO poisoning, characterized by regional or global left ventricular wall hypokinesia
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INTRODUCTION
Carbon monoxide (CO) is a tasteless, odourless, gaseous pollutant generated by incomplete combustion of carbonaceous material. Gasoline-
powered heat generators, indoor use of charcoal briquettes or exposure to CO from fire or intentionally as a suicide attempt are common 
aetiologies of toxicity. Almost 1,300 deaths are attributed to CO exposure annually in the United States. Even short-term exposure to low 
CO levels has been implicated in impaired central nervous system function, coronary heart disease (CHD), arrhythmias and heart failure 
(HF), especially in the elderly and in patients with pre-existing disease.
A case of a healthy young patient with severe HF as a consequence of acute CO poisoning is described here. 
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CASE DESCRIPTION  
A 28-year-old male was transferred to the Emergency Department (ED) with reduced levels of consciousness and reported seizures after 
the use of charcoal briquettes for heating all night. His medical history was free (no medication, smoking habits or alcohol intake). 
Clinical examination revealed tachypnoea [respiratory rate (RR)=30 breaths/min], tachycardia (110 bpm), diffuse bilateral rales on lung 
auscultation and dilated jugular veins. Arterial pressure (AP), temperature, cardiac auscultation, abdominal palpation and oxygen saturation 
(sO
2
) were normal (he was transferred with oxygen administration). No signs of peripheral pitting oedema were noticed. Neurologically, 
the patient was severely confused with a reduced Glasgow Coma Scale score (GCS=9, pain localization, concurrent eye-opening, 
incomprehensible sounds) and no focal neurologic signs or neck stiffness. 
Laboratory investigation was normal except for white blood cells (18,820/μl, neutrophils 16,600/μl) and C-reactive protein (1.89 mg/dl, 






=35.1 mmHg, pH=7.431, 
lactate=2.9 mmol/l, HCO
3
=23 mmol/l, COHb=29.5%. An electrocardiogram (ECG) showed no ischaemia. Thoracic X-ray depicted diffuse, 
bilateral infiltrates of the lower lung fields, compatible with pulmonary oedema (Fig. 1A). Brain computed tomography (CT) did not show 
cerebral oedema or focal lesions. An echocardiogram revealed severe HF [ejection fraction (EF) <25%] with diffuse, global hypokinesia and 
a dilated inferior vena cava with reduced respiratory fluctuation. High-sensitivity troponin I was 124 ng/l (<29 ng/l), whereas the other 
cardiac biomarkers were normal. Four hours later (while intubated), lactate was 1.83 mmol/l and COHb 2.5%.
During his evaluation in the ED, the patient had a dramatic deterioration (AP=75/50 mmHg, RR=50 breaths/min, sO2=80% despite 100% 
oxygen rate) and became comatose. He was intubated and transferred to the Intensive Care Unit (ICU). His appointment for emergent 
hyperbaric oxygen therapy (HOT) at the National Center (160 km away) was cancelled because of his unstable condition. The patient 
remained in the ICU for 5 days and was haemodynamically stable after the first day (without norepinephrine administration). A second brain 
CT confirmed the absence of oedema. He presented fever up to 38°C, which subsided on the third day after initiation of meropenem (2 g ×3) 
and linezolid (600 mg ×2). An echocardiogram showed excellent improvement of left ventricular contractility (EF>55%). Troponin I levels 
were within normal limits.
The patient gradually regained consciousness after the fourth day, without memory problems or other neurologic deficits. He was transferred 
to the Internal Medicine Department for completion of treatment and rehabilitation. He was discharged 1 week later with full recovery (Fig. 
1B). Neurologic and psychiatric evaluation 1 month later was normal.
Figure 1. Bilateral infiltrates of the lower lung fields, compatible with 
pulmonary oedema, during the initial episode of acute heart failure 
(A, supine position), with excellent improvement before discharge (B, 
upright position)
DISCUSSION
Cellular hypoxia after CO exposure is caused by disturbances of oxygen delivery. CO reversibly binds haemoglobin (230–270 times more 
powerfully than oxygen) and cardiac myoglobin with even greater affinity. Additionally, CO causes a leftward shift of the oxyhaemoglobin 
dissociation curve, further decreasing oxygen availability. However, impaired oxygen delivery does not sufficiently explain the extent of 
toxicity. CO may cause direct cellular damage involving immunological or inflammatory mechanisms (peroxynitrite production, reactive 
oxygen species, lipid peroxidation, mitochondrial oxidative stress, nitric oxide free radicals, platelet activation). The CO half-life is 3–4 
hours. 100% oxygen reduces this to 30–90 minutes and HOT (2.5 atmospheres, 100% oxygen) to 15–23 minutes.
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The most profound impact is noticed on organs with the highest oxygen requirements (brain, heart). Symptoms typically begin with headaches 
(COHb=10%), progressing to memory problems, confusion, hallucinations, abdominal discomfort (pain, vomiting), visual disturbances and 
seizures, leading to coma or even death (levels up to 50–70%). Patients with CHD may experience angina or arrhythmias with COHb levels 
of just 5–10%, whereas at higher levels even young patients develop myocardial depression[1, 2]. The most common electrophysiologic 
abnormality is disruption of repolarization and prolongation of the QT interval. Since 1928 (the first recorded case of angina), many reports, 
even those from young children, have documented the influence of CO on coronary vessels. HF and pulmonary oedema are an unusual 
complication, mainly in patients with pre-existing disease. Myocardial dysfunction may present as regional wall motion abnormality or 
global left ventricular dysfunction. Lee et al. presented a case of left ventricular dysfunction with concomitant intraventricular thrombus and 
Swank et al., a case of reversible acute HF[3, 4]. Yanir et al. reported two previously healthy young patients with cardiogenic shock, whereas 
Kuniavsky et al., a young patient with HF and complete recovery after HOT[5, 6]. 
Physical examination is of limited diagnostic value as findings are non-specific. Inhalation injury or burns should always alert the clinician to 
the possibility of CO exposure. Cherry-red skin, though rare, has been considered a sign of CO poisoning. Ophthalmologic examination may 
reveal bright-red retinal veins (a sensitive early sign) or papilloedema. 
Diagnosis of acute CO poisoning must be confirmed by elevated COHb levels (3–4% in non-smokers, 10% in smokers), which may be reduced 
due to prior oxygen administration or a prolonged period since exposure. In patients with severe poisoning, ECG and cardiac biomarkers 
should be obtained. Elevated troponin I levels indicate cardiomyopathy or myocardial ischaemia, which is a predictor of mortality. Increased 
lactate levels are a severity index and correlate with neurologic outcome (levels >10 mmol/l may indicate concomitant cyanide poisoning). 
A brain CT scan may reveal cerebral oedema and/or focal low-density lesions (typically in the basal ganglia), which may predict permanent 
neurologic sequelae. Magnetic resonance imaging, diffusion-weighted and diffusion tensor imaging are more accurate and can visualize 
pathologic changes in the early stages. A late finding is diffuse cerebral atrophy due to neuronal necrosis and apoptosis. 
HOT contributes to prompt elimination of COHb and may diminish permanent cognitive sequelae or mortality. Selection criteria (regardless 
of the COHb levels) include coma, cardiac ischaemia, focal neurologic deficits or neuropsychiatric disorders. Treatment complications may 
be decompression sickness, sinus and ear barotrauma, seizures, pneumothorax, gas embolism or visual disturbances.
Despite aggressive treatment, many survivors (up to 19–37% after 6 years of poisoning) are at risk for permanent neurologic and psychiatric 
complications (memory loss, irritability, movement or speech disorders, depression, psychosis, suicidal tendency). Mortality is significant, 
even in small children, and depends on COHb levels, encephalopathy, cardiomyopathy, duration of cardiopulmonary arrest, delayed 
treatment and co-morbidities.
CONCLUSION
Acute HF is a rare, serious but potentially reversible complication of CO poisoning. Aggressive treatment, and particularly, pre-hospital 
supportive care and urgent transfer to the hospital are life-saving. 
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